Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human DiseasePACHER, Pal; SZABO, Csaba.The American journal of pathology. 2008, Vol 173, Num 1, pp 2-13, issn 0002-9440, 12 p.Article

Trends in the development of new antidepressants. Is there a light at the end of the tunnel?PACHER, Pal; KECSKEMETI, Valeria.Current medicinal chemistry. 2004, Vol 11, Num 7, pp 925-943, issn 0929-8673, 19 p.Article

Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells : implications for inflammatory liver diseasesPACHER, Pal; BIN GAO.American journal of physiology. Gastrointestinal and liver physiology. 2008, Vol 57, Num 4, issn 0193-1857, G850-G854Article

Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases : The therapeutic potential of PARP inhibitorsPACHER, Pal; SZABO, Csaba.Cardiovascular drug reviews (Print). 2007, Vol 25, Num 3, pp 235-260, issn 0897-5957, 26 p.Article

Cardiovascular side effects of new antidepressants and antipsychotics: New drugs, old concerns? : Agents acting on cardic and smooth musclesPACHER, Pal; KECSKEMETI, Valeria.Current pharmaceutical design. 2004, Vol 10, Num 20, pp 2463-2475, issn 1381-6128, 13 p.Article

Targeting cannabinoid receptor CB₂ in cardiovascular disorders: promises and controversiesSTEFFENS, Sabine; PACHER, Pál.British journal of pharmacology. 2012, Vol 167, Num 2, pp 313-323, issn 0007-1188, 11 p.Article

Interplay of cannabinoid 2 (CB₂) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegenerationPACHER, Pál; MACKIE, Ken.Journal of molecular medicine (Berlin. Print). 2012, Vol 90, Num 4, pp 347-351, issn 0946-2716, 5 p.Article

Regulation of Macrophage Function by Adenosine : The Role of Adenosine in Response to Vascular InflammationHASKO, György; PACHER, Pál.Arteriosclerosis, thrombosis, and vascular biology. 2012, Vol 32, Num 4, pp 865-869, issn 1079-5642, 5 p.Article

Current trends in the development of new antidepressantsPACHER, Pal; KOHEGYI, Eva; KECSKEMETI, Valeria et al.Current medicinal chemistry. 2001, Vol 8, Num 2, pp 89-100, issn 0929-8673Article

The emerging role of the endocannabinoid system in cardiovascular diseasePACHER, Pal; STEFFENS, Sabine.Seminars in immunopathology (Print). 2009, Vol 31, Num 1, pp 63-77, issn 1863-2297, 15 p.Article

Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary DiseaseSTASCH, Johannes-Peter; PACHER, Pál; EVGENOV, Oleg V et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 20, pp 2263-2273, issn 0009-7322, 11 p.Article

The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic ComplicationsHORVATH, Béla; MUKHOPADHYAY, Partha; HASKO, György et al.The American journal of pathology. 2012, Vol 180, Num 2, pp 432-442, issn 0002-9440, 11 p.Article

Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth musclePACHER, Pal; UNGVARI, Zoltan; KECSKEMETI, Valéria et al.Canadian journal of physiology and pharmacology. 2001, Vol 79, Num 7, pp 580-584, issn 0008-4212Article

Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategiesPACHER, Pal; OBROSOVA, Irina G; MABLEY, Jon G et al.Current medicinal chemistry. 2005, Vol 12, Num 3, pp 267-275, issn 0929-8673, 9 p.Article

Role of nonsynaptic communication in regulating the immune response : Non-synaptic transmissionSELMECZY, Zsolt; VIZI, E. Sylvester; CSOKA, Balazs et al.Neurochemistry international. 2008, Vol 52, Num 1-2, pp 52-59, issn 0197-0186, 8 p.Article

Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in Chronic heart failurePACHER, Pal; LIAUDET, Lucas; MABLEY, Jon G et al.Journal of the American College of Cardiology. 2002, Vol 40, Num 5, pp 1006-1016, issn 0735-1097Article

Alcohol and mitochondria in cardiac apoptosis : Mechanisms and visualizationHAJNOCZKY, György; BUZAS, Christopher J; PACHER, Pal et al.Alcoholism, clinical and experimental research. 2005, Vol 29, Num 5, pp 693-701, issn 0145-6008, 9 p.Article

Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptorsBATKAI, Sandor; PACHER, Pal; JARAI, Zoltan et al.American journal of physiology. Heart and circulatory physiology. 2004, Vol 56, Num 2, pp 595-600, issn 0363-6135, 6 p.Article

Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicityBAI, Péter; MABLEY, Jon G; LIAUDET, Lucas et al.Oncology reports. 2004, Vol 11, Num 2, pp 505-508, issn 1021-335X, 4 p.Article

Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymeraseGARCIA SORIANO, Francisco; PACHER, Pal; MABLEY, Jon et al.Circulation research. 2001, Vol 89, Num 8, pp 684-691, issn 0009-7330Article

Modulation of the Endocannabinoid System in Cardiovascular Disease : Therapeutic Potential and LimitationsPACHER, Pal; MUKHOPADHYAY, Partha; MOHANRAJ, Rajesh et al.Hypertension (Dallas, Tex. 1979). 2008, Vol 52, Num 4, pp 601-607, issn 0194-911X, 7 p.Article

Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activationPACHER, Pal; MABLEY, Jon G; SORIANO, Francisco G et al.British journal of pharmacology. 2002, Vol 135, Num 6, pp 1347-1350, issn 0007-1188Article

New trends in the development of oral antidiabetic drugsKECSKEMETI, Valeria; BAGI, Zsolt; PACHER, Pal et al.Current medicinal chemistry. 2002, Vol 9, Num 1, pp 53-71, issn 0929-8673Article

The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetesPACHER, Pal; LIAUDET, Lucas; GARCIA SORIANO, Francisco et al.Diabetes (New York, NY). 2002, Vol 51, Num 2, pp 514-521, issn 0012-1797Article

Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicityHAO PAN; ZHOUJUN SHEN; MUKHOPADHYAY, Partha et al.American journal of physiology. Renal physiology. 2009, Vol 65, Num 3, issn 1931-857X, F496-F504Article